Literature DB >> 34129118

Same-day discharge arthroplasty has a higher overall complications rate than fast-track arthroplasty: a systematic review and meta-analysis.

Mingyang Li1, Rong Luo1, Yi Zeng1, Yuangang Wu1, Yuan Liu1, Limin Wu1, Bin Shen2.   

Abstract

BACKGROUND: Published studies have reported many inconsistent results regarding the comparison of same-day discharge total joint arthroplasty (TJA) and inpatient TJA. More notably, many recent studies comparing same-day discharge TJA with fast-track TJA presented higher rates of complications for same-day discharge TJA, which raises concerns about the safety of same-day discharge TJA.
METHODS: We systematically searched the MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases up to June 2020 for studies comparing mortality, readmission, and complications in same-day discharge and inpatient total hip or knee arthroplasty. Studies that used inpatient TJA as the control could be further divided into fast-track inpatient TJA (length of stay [LOS] ≤ 2 days) and traditional inpatient TJA (no restrictions on LOS). Relative risks were pooled to compare the outcomes of the same-day discharge group and the control group.
RESULTS: According to selection criteria and quality assessment, 14 studies including 222,766 cases were identified. There was no significant difference in the risk of mortality (RR = 1.42, CI [0.67, 3.01]) or readmission (RR = 0.93, CI [0.79, 1.10]) between same-day discharge TJA and inpatient TJA. Compared with fast-track TJA, the rate of overall complications in same-day discharge TJA was significantly higher (RR = 1.67, CI [1.45, 1.93]), while the rates of overall complications were similar between same-day discharge and traditional inpatient TJA (RR = 0.83, CI [0.67, 1.03]).
CONCLUSION: The overall safety of same-day discharge TJA is satisfactory; however, more complications were detected in same-day discharge TJA than that in fast-track TJA. Complications in same-day discharge TJA might be underestimated in some previous studies taking long-staying inpatient TJA as control. Being more cautious about complications is necessary in the care of same-day discharge TJA, and extensive prospective studies are needed to explore the optimized option that weighs both cost and complications.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Complication rate; Fast-track arthroplasty; Same-day discharge arthroplasty

Mesh:

Year:  2021        PMID: 34129118     DOI: 10.1007/s00402-021-03883-3

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  5 in total

Review 1.  Outpatient Total Hip Arthroplasty, Total Knee Arthroplasty, and Unicompartmental Knee Arthroplasty: A Systematic Review of the Literature.

Authors:  Michael Pollock; Lyndsay Somerville; Andrew Firth; Brent Lanting
Journal:  JBJS Rev       Date:  2016-12-27

2.  Perlecan is required for the chondrogenic differentiation of synovial mesenchymal cells through regulation of Sox9 gene expression.

Authors:  Ryo Sadatsuki; Haruka Kaneko; Mayuko Kinoshita; Ippei Futami; Risa Nonaka; Kirsty L Culley; Miguel Otero; Shinnosuke Hada; Mary B Goldring; Yoshihiko Yamada; Kazuo Kaneko; Eri Arikawa-Hirasawa; Muneaki Ishijima
Journal:  J Orthop Res       Date:  2016-06-15       Impact factor: 3.494

Review 3.  Safety and efficacy of outpatient hip and knee arthroplasty: a systematic review with meta-analysis.

Authors:  Y F L Bemelmans; M H F Keulen; M Heymans; E H van Haaren; B Boonen; M G M Schotanus
Journal:  Arch Orthop Trauma Surg       Date:  2021-02-15       Impact factor: 2.928

4.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21

5.  Outpatient vs. inpatient hip arthroplasty: a matched case-control study on a 90-day complication rate and 2-year patient-reported outcomes.

Authors:  Philip J Rosinsky; Sarah L Chen; Mitchell J Yelton; Ajay C Lall; David R Maldonado; Jacob Shapira; Mitchell B Meghpara; Benjamin G Domb
Journal:  J Orthop Surg Res       Date:  2020-08-31       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.